ERIC LAVIADDIN: Open Payments
NPI 1245546860 · CANOGA PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 19 payments from 8 companies in 2025. Trend: 2023 $882 · 2024 $292 · 2025 $588
Food & beverage: $546Education: $43
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $124 |
| Mannkind Corporation | 3 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $94 |
| Lilly USA, LLC | 3 | $88 |
| GlaxoSmithKline, LLC. | 3 | $83 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $29 |
Products named: Kerendia, AFREZZA, JARDIANCE, MOUNJARO, TRELEGY ELLIPTA, JOURNAVX, VOQUEZNA, ELIQUIS.
Industry payments across CA — which companies pay providers there.
